Mrs. Beki Michele Mitchell, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2026 E 140th Pl S, Bixby, OK 74008 Phone: 918-366-3320 |
Christina M Bell, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11986 S 91st East Ave, Bixby, OK 74008 Phone: 918-691-4937 |
Lana Neafus Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3632 E 143rd St S, Bixby, OK 74008 Phone: 918-633-0940 |
Mrs. Amanda Kay Gammill, M.S CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9401 E 161st St S, Bixby, OK 74008 Phone: 918-366-2249 |
Aday Of Speech Therapy L.l.c. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5822 E 145th St S, Bixby, OK 74008 Phone: 602-377-6542 |
Jessica Thompson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7701 E. 121st, Bixby, OK 74008 Phone: 918-409-8205 |
The Speech Easy Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 184 Summer Valley Rd, Blanchard, OK 73010 Phone: 405-201-3733 |
Mrs. Lendy Kay Duncan, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 485 Summer Valley Rd, Blanchard, OK 73010 Phone: 580-317-5848 |
Kristi York-bonds Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1605 Maple St, Blanchard, OK 73010 Phone: 405-708-1919 |
Driskell Speech Services, Pllc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 Se 2nd St, Blanchard, OK 73010 Phone: 405-779-3270 Fax: 405-293-3500 |
Ms. Andrea M Driskell, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 Se 2nd St, Blanchard, OK 73010 Phone: 405-779-3270 |
Ashley Owens, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 Se 2nd St, Blanchard, OK 73010 Phone: 405-779-3270 Fax: 405-561-4806 |
Molly Ann Ita, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 25252 Roselawn Rd, Blanchard, OK 73010 Phone: 405-485-3347 |
Mrs. Tara Michelle Stephens, MS CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 25888 May Ave, Blanchard, OK 73010 Phone: 405-485-3650 |
Mrs. Amy L Minor, M.A. CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1051 S Mustang Rd, Blanchard, OK 73010 Phone: 405-301-6238 |
Mrs. Cindy Diane Walker, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8147 Shadow Lake Dr, Blanchard, OK 73010 Phone: 405-245-6190 |
Mrs. Stephanie Michelle Thomas, M.S.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2286 Cottage Lane, Blanchard, OK 73010 Phone: 405-401-0875 Fax: 405-756-8191 |
Jarred Curtis Luesada, MS-CCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5429 Quail Ridge Rd, Blanchard, OK 73010 Phone: 405-990-5262 Fax: 405-387-3056 |
Amanda Zink, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2405 County Street 2960, Blanchard, OK 73010 Phone: 405-574-5681 |
Mrs. Rebecca Bell, M.ED. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 700 Pierce Rd, Bokoshe, OK 74930 Phone: 918-658-8304 |
News Archive
Patients with chronic kidney disease are commonly exposed to nocturnal hypoxia that may increase the rate of decline in kidney function, Canadian researchers report.
Researchers at the University of Oxford, in collaboration with colleagues from Hannover Medical School and Martin-Luther-University Halle-Wittenberg, have discovered the specific gene mutations that are required for the development of leukemia in children with Down's syndrome.
A study featured in the November issue of the Journal of Thoracic Oncology confirms the success of a simple questionnaire designed to identify patients at high risk of lung cancer. Initiated in 2001, the current study confirmed 18 cases of cancer of the original 430 patients who qualified as high risk after completing a five-minute questionnaire
Takeda Pharmaceutical Company Limited today announced that the company will present data from its expanding oncology pipeline and established product portfolio at two upcoming virtual scientific congresses: the 56th Annual Meeting of the American Society of Clinical Oncology, May 29-31 and the 25th Virtual Congress of the European Hematology Association, June 11-14.
› Verified 3 days ago